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Abstract
Background: The developments in echocardiography or ultrasound cardiography (UCG) have
improved our clinical capabilities. However, advanced hardware and software capabilities have
resulted in UCG facilities of dubious clinical benefits. Is tissue Doppler echocardiography (TDE) is
one such example?
Presentation of the hypothesis: TDE has been touted as advancement in the field of
echocardiography. The striking play of colors, impressive waveforms and the seemingly accurate
velocity values could be deceptive. TDE is a clear case of inappropriate use of technology.
Testing the hypothesis: To understand this, a comparison between flow Doppler and tissue
Doppler is made. To make clinically meaningful velocity measurements with Doppler, we need
prior knowledge of the line of motion. This is possible in blood flow but impossible in the complex
myocardial motion. The qualitative comparison makes it evident that Doppler is best suited for flow
studies.
Implications of the hypothesis: As of now TDE is going backwards using an indirect method
when direct methods are better. The work on TDE at present is only debatable 'research and
publication' material and do not translate into tangible clinical benefits. There are several advances
like curved M-mode, strain rate imaging and tissue tracking in TDE. However these have been
disappointing. This is due to the basic flaw in the application of the principles of Doppler. Doppler
is best suited for flow studies and applying it to tissue motion is illogical. All data obtained by TDE
is scientifically incorrect. This makes all the published papers on the subject flawed. Making
diagnostic decisions based on this faulty application of technology would be unacceptable to the
scientific cardiologist.
Background
Echocardiography or Ultrasound Cardiography (UCG) is
a key investigation in cardiology. Its non-invasive nature
makes it a widely acceptable and safe form of investiga-
tion. In many cases it has surpassed cardiac catheterisa-
tion in diagnostic yield and has become the investigation
of choice.
The rapid development of UCG has made available to the
clinician newer insights into the anatomy and physiology
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of the heart. With the availability of digital technology it
is possible to manipulate raw data in different ways. This
has also spawned UCG facilities of dubious clinical bene-
fits. Tissue doppler echocardiography (TDE) is one such
example.
When we consider UCG we are interested in 2 distinct
aspects of the heart:
1. Structure 2. Blood flow. Both these ultimately indicate
cardiac function. B-mode/M-mode imaging or simply
Ultrasound Imaging (USI) studies structure. Blood flow is
studied by Doppler studies (DS). In each stream every
development should incrementally improve our under-
standing of the heart, its structure and function. Or the
development should improve the ease of operation or
permit better documentation.
In USI we had the following developments and each
development added to the diagnostic yield. M-mode –
temporal resolution; 2D – spatial resolution; Harmonic
imaging – improvement in image quality; B-color –
enhanced tissue perception; Ultrasonic tissue characteri-
zation and acoustic quantification – quantitative analysis
of tissue; Omni-plane M-mode – temporal resolution at
different segments and 3D imaging – another dimension
of imaging.
In DS too we had many developments, each improving
our perception. Continuous wave (CW) – detected and
measured high velocity flows; Pulse wave (PW) – located
the abnormal flow; Color flow mapping (CFM) – made it
possible to 'image' blood flows and power amplitude
Doppler – to study vascular flow. Contrast, trans-
oesophageal and intravascular UCG are the clinical exten-
sions and exploitation of these developments
What we see in TDE is a retrograde development. In the
context of UCG, DS is an indirect method to study blood
flow since USI in its present state cannot image fast mov-
ing blood cells. Spontaneous echo contrasts could mark
the beginning of USI of blood cells. By using TDE we are
using an indirect method where direct USI methods are
better. Besides, TDE is an inappropriate application of the
Doppler methodology.
Presentation of the hypothesis
TDE is a by-product of color flow mapping (CFM) tech-
nology. In CFM, tissue signals are suppressed and flow sig-
nals are analyzed. The reverse is true in TDE. Doppler
velocities associated with tissue motion are slower than
blood flow. Flow signals are eliminated on the basis of
signal amplitude. The amplitude of tissue motion is about
40 db greater than the corresponding flow amplitude.
Blood flow imaging applies a high pass filter to exclude
the strong but low frequency tissue signals and other
'noise' before the signal is input into an autocorrelator
that estimates velocity.[1] Erroneous filter settings could
cause the autocorrelator to include components of tissue
signals so that tissue velocities become encoded. This
principle has been legitimized to color code tissue motion
and we get an 'image' which is entirely Doppler informa-
tion. In this discussion TDE includes both pulse tissue
Doppler and color tissue Doppler (also known as Doppler
tissue imaging or tissue velocity imaging).
The first report on the use of TDE appeared in 1989.[2]
However the real development and the widespread use of
this technique started after the publication of the valida-
tion work of TDE setting the 'scientific' basis for the quan-
titative analysis of myocardial velocities in real time.[3]
There are several papers on the use of TDE.[4,5] Various
values and indices are already in place.[6,7] Over the past
few years technological advances in TDE like curved M-
mode, strain rate imaging and tissue tracking have been
developed. These are in addition to modalities like the
phase imaging, amplitude imaging and acceleration imag-
ing.[8] Text books on TDE has also been added to the
number of books already available on UCG.[9] Even now
there are a number of papers on tissue Doppler echocardi-
ography (TDE) appearing in leading journals.[10] Is TDE
methodology correct? Is it in agreement with the Doppler
principles? Has TDE made any tangible improvement in
the already available UCG techniques? Has TDE improved
our diagnostic yield? This article presents the hypothesis
that TDE is a flawed application of Doppler and hence
data collection with TDE is erroneous.
Testing the hypothesis
The article explains the flaws in tissue Doppler echocardi-
ography. As the concept itself is flawed, all data using this
modality is flawed. You cannot even think of designing a
study to prove the point because the mensuration tech-
nique itself is wrong. So we have to use the scientific
methods of comparison and reductio ad absurdum to verify
it. Any new modality of diagnosis or treatment should be
compared with the existing systems. In clinical trials we
usually employ quantitative  comparison with statistical
methods. In this case, since the data acquisition is flawed
we have to use a qualitative comparison. This is accepted
practice in clinical medicine – It is like comparing a weak
limb with the strong one in neurology. One also needs to
understand the Doppler methodology to test the hypoth-
esis.
The Doppler methodology
To estimate clinically significant peak Doppler velocity
the following steps are required:Cardiovascular Ultrasound 2004, 2:12 http://www.cardiovascularultrasound.com/content/2/1/12
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1. You must have prior knowledge of the line of motion of
the object. Only if you know this line of motion, you can
apply the interrogating signal along the path of motion.
This is because of the directional bias of Doppler.
2. Next you will know the direction of motion – whether
the object is moving towards the interrogating signal or
away.
3. Only after the first two steps you can measure the clin-
ically significant peak velocity.
Based on the above discussion it is clear that the following
information can be derived from Doppler:
1. Is there motion? Does the object move? This is a ran-
dom application of Doppler. This is one aspect of tissue
Doppler. But this information is redundant as we can
already see the movement better by ultrasound imaging.
2. What is the direction of motion? Is it moving towards
or away from the interrogating signal? This is also redun-
dant information in tissue Doppler for the reason given
above.
3. To measure the peak significant velocity we must know
the clear-cut line of motion. Application of Doppler along
this line enables us to measure the meaningful peak veloc-
ity.
Thus the primary step is to know the line of motion. This
is possible in flow Doppler but impossible in tissue Dop-
pler. For example we know for sure that the blood moves
from left atrium to left ventricle through the mitral valve.
At the mitral valve this is a unique free linear motion
towards the apex. This produces a clinically significant
velocity. That is why we place the sample volume at the
mitral valve from apical views so as to align the beam in
the line of anticipated flow. That is also why we do not
measure the mitral flow velocity from the parasternal
views. Next we come to learn whether the blood is flowing
towards or away from the transducer. After all these steps
it is possible to measure velocity. In tissue Doppler we can
measure several velocities in several directions. But we can
never know which is the clinically significant peak veloc-
ity.
Flaws in TDE
TDE is a clear case of misuse of technology. To understand
this, a comparison between flow Doppler and tissue Dop-
pler is in order. CFM allows us to 'see' what we cannot see
with ultrasonic 'eyes' hence its value is great. In color TDE
we see more or less what we already see by USI hence its
value is marginal. In CFM the anatomic landmarks are
intact as the color is superimposed on the B-mode image.
In color TDE the B-mode is eliminated and the entire 'pic-
ture' is Doppler information. It is difficult to determine
the different anatomic regions on TDE. For example it
would be very difficult to delineate the blood-endocardial
boundary. In fact, the word 'tissue Doppler' is a misnomer
and this is one of the reasons for the prevailing confusion.
It gives the impression that only myocardial tissues are
studied. The appropriate term would have been low veloc-
ity Doppler. Any movement in the low velocity range will
be detected by 'tissue Doppler'. Myocardial tissue move-
ment is just one among them. The discriminatory power
of this modality is unsatisfactory.
Myocardial motion is very complex and not amenable to
Doppler studies. In the cardiac motion there are transla-
tional, rotational and deformational movements. Besides
many tissues near the heart move – due to transmitted car-
diac motion, vessel pulsation, respiratory motion and
involuntary muscle movements and these interact with
cardiac motion further and cause false Doppler shifts.[1]
Velocity is a vector quantity and so Doppler interrogation
at one point will determine the velocity of the resultant of
all these movements projected in the line of the Doppler
beam with angle correction. Similarly at a particular point
there are movements in several axes and we can never pre-
dict the sum resultant vector. Even if known, the resultant
is accurately recorded only if it is in the line of the Doppler
beam. This is due to the inherent problem of directional
bias. It is like measuring the length of a twisted rod
directly with a straight rigid ruler. In the case of strain rate
imaging, the protagonists have substituted a vector quan-
tity (velocity) for a scalar quantity (length) in the original
formula of strain calculation.[11] This would be mathe-
matically unacceptable. Cardiac motion becomes more
complicated in the presence of wall motion abnormali-
ties.
Blood flow is simple and suitable for Doppler study. In
flow Doppler at a particular point the linear projectile
motion of free moving blood cells are studied. At the cur-
rent interrogation points there is a unique unidirectional
flow in one part of the cardiac cycle. For example in mitral
valve Doppler interrogation, the unique directional signal
is obtained only in diastole. If there is a signal in the in
systole, it becomes abnormal and this information has
great value. In TDE the to- and- fro motion (systole and
diastole) of a tethered interconnected syncytium of myo-
cytes is imaged. Such information is useless. This can be
even otherwise seen and analyzed by USI.
In flow Doppler there are definite 'points of interroga-
tion', which are the normal and abnormal orifices. In TDE
there are no such definite points. While in flow Doppler
higher velocities are studied, TDE studies lower velocities
i.e. the study of hypo functioning myocardial segments.Cardiovascular Ultrasound 2004, 2:12 http://www.cardiovascularultrasound.com/content/2/1/12
Page 4 of 6
(page number not for citation purposes)
Lower velocities are difficult to appreciate. The higher
velocities are easier to appreciate due to aliasing and vari-
ance. There are no such indicators for low velocity. Thus
hypo function is difficult to analyze. The derivations from
flow Doppler are based on accepted hydrodynamic for-
mulae (like Bernoulli's equation) and allows us to get ori-
fice size, amount of flow and pressure gradients, which are
clinically of great importance. The derivations from TDE
are useless. Thus Doppler in its present form, is best suited to
study flow.
Implications of the hypothesis
TDE has shown some promise in the Wolff-Parkinson-
White syndrome.[12] But even here by having a high
frame rate or by using the omni plane M-mode, we could
be able to locate the pre-excited tissue by USI. Diastolic
dysfunction in pseudo-normalized mitral Doppler spec-
trum and in atrial fibrillation are other areas where TDE is
found useful.[13,14] Here the benefits are marginal as
there are other parameters to study diastolic dysfunc-
tion.[15] Besides, the determination of diastolic dysfunc-
tion by Doppler in clinical practice may not be
sacrosanct.[16] It has been used as a method to differenti-
ate between constrictive pericarditis and restrictive cardio-
myopathy.[17] Here its role is supplementary and does
not provide critical distinction. The main role of TDE as a
method of detecting regional wall motion abnormalities
has been stressed.[18] Here again it is complementary to
routine USI. TDE is being used in the study of cardiac
transplant rejection.[19] In this situation the results are
not clear and there are other better UCG methods to study
rejection.[20,21] TDE has been advocated in planning
and follow-up of cardiac re-synchronization ther-
apy.[22,23] Here again the conventional methods are ade-
quate[24,25] and the false-positive data (see below) may
be confounding. Besides several issues regarding the ther-
apy need to be settled.[26] Mitral annular tissue velocities
have been used in the determination of left ventricular fill-
ing pressures.[27] Here again an 'hydrodynamic' informa-
tion (fluid pressure) is derived from non-hydrodynamic
(tissue velocity) measurement. Mitral annulus is a circular
area. As mentioned earlier here also we cannot define the
precise point of interrogation. An infinite number of val-
ues can be obtained all around the mitral annulus. It is
important to note that in all the above papers the data acquired
is flawed due to the basic problem in technology application.
Hence the correlations obtained in these papers are spurious or
non-sense correlations. One paper presents a misuse of sta-
tistics when tissue Doppler velocities have been correlated
with myocardial interstitial fibrosis and myocyte intersti-
tial beta-adrenergic receptor density.[28] By analogy,
using a little statistical jugglery, we could find correlation
between blood cholesterol levels and flow Doppler indi-
ces. All these papers are mentioned just for completeness.
Accepting the data in these papers would be tantamount
to rejecting the Doppler principle and methodology. As of
now TDE is going backwards using an indirect method
where direct methods are available. The work on TDE at
present is only debatable 'research and publication' mate-
rial and does not translate into tangible clinical benefits.
The prime use of TDE is to study regional wall motion
abnormalities. It is claimed that it is possible to quantify
wall motion at rest and during stress. However with the
above-mentioned limitations it is unlikely to prove more
effective than USI. The measurements are ultra sensitive
and represent gross movements rather than myocyte con-
tractions. With the advent of omni-plane M-mode it is
possible to get temporal resolution in inaccessible planes
and study wall motion abnormalities in a better way.
The Doppler methods use mathematical formulae to indi-
rectly study motion that cannot be directly measured.
Examples are movements of stellar bodies and in the
present context movements of blood cells. We use the
indirect method based on Doppler principle because we
cannot 'image' blood cells by USI. When the imaging of
blood cells become possible, Doppler studies would
probably be relegated to the background. Color TDE
would have been valuable if direct USI was not available.
Tissue Doppler has been a disappointing modality in clin-
ical ultrasound cardiology. This is due to the basic flaw in
the application of the principles of Doppler. Doppler is
best suited for flow studies and applying it to tissue
motion is not acceptable. In flow Doppler we suppress the
tissue 'noise' and display flow.[1] In TDE it is the other
way round. Besides TDE is ultra sensitive and so the infor-
mation gathered is almost useless (too many false positive
information). In fact excellent cardiac waveforms can be
obtained by placing the sample volume just outside the
cardiac region! This is also the reason why it is useless for
even studying the temporal aspects of the cardiac cycle
and waveform analysis. Once the foundation of a modal-
ity is wrong, all derivations tend to be wrong.
However the author is of the view that TDE could proba-
bly have some role in diagnostic UCG. What is required is
that Doppler should be used for the purpose it was
intended i.e. to study blood flow. Thus we will have 2
types of Doppler studies: High velocity flow Doppler
(HVFD) studies and Low velocity flow Doppler (LVFD)
studies. Conventional Doppler would be HVFD. TDE
would be LVFD and we would be imaging and analyzing
very low velocity flows. The possible uses of color LVFD
studies would be the study of low flow thrombogenic
states, flow in the atria, the blood-endocardial/endothe-
lial interface, low velocity turbulences and blood flow in
organs. Pulse wave spectral LVFD could be useful for the
detection of low velocity turbulences as a cause for mur-Cardiovascular Ultrasound 2004, 2:12 http://www.cardiovascularultrasound.com/content/2/1/12
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murs (not detectable with HVFD). These are potential areas
for investigation and research.
It is time to look at TDE on more realistic terms. As a new
modality of imaging it appears exciting. But its real clini-
cal utility is doubtful. TDE does not give any additional
information over the conventional modalities. In fact due
to the above-mentioned deficiencies it could give mislead-
ing information. Making diagnostic and therapeutic deci-
sions based on this faulty application of technology
would be unacceptable to the scientific cardiologist.
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